Oncobiologics (OTLK) Earnings Date, Estimates & Call Transcripts $1.21 +0.04 (+3.16%) As of 09:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oncobiologics Earnings Summary Oncobiologics announced Q3 2025 earnings on August 14, 2025, reporting an EPS of -$0.44, which missed analysts' consensus estimates of -$0.42 by $0.02. Quarterly revenue was reported to be $1.51 million, below the consensus estimate of $1.66 million. With a trailing EPS of -$0.57, Oncobiologics' earnings are expected to grow next year, from ($2.27) to ($0.20) per share. Upcoming Q4 Earnings DateDec. 26Before Market OpensEstimatedConsensus EPS (Aug. 14) -$0.42 Actual EPS (Aug. 14) -$0.44 Missed By -$0.02 Actual Revenue (Aug. 14) $1.51MQ3 2025 Earnings ResourcesQ3 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)OTLK Upcoming EarningsOncobiologics' next earnings date is estimated for Friday, December 26, 2025, based on past reporting schedules. Powered by Get Oncobiologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncobiologics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataOTLK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Oncobiologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.99-$0.70-$0.85Q2 20252-$0.60-$0.53-$0.57Q3 20252-$0.51-$0.29-$0.40 Oncobiologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 12/26/2025(Estimated)--------8/14/2025Q3 2025-$0.42-$0.44 -$0.02-$0.55$1.66M$1.51M5/15/2025Q2 2025-$0.55-$0.40+$0.15-$1.50$0.70M-2/14/2025Q1 2025-$0.85-$0.89 -$0.04$0.72--12/27/2024Q4 2024-$0.83-$0.77+$0.06$0.76--8/14/2024Q3 2024-$1.06-$0.83+$0.23-$0.77--5/15/2024Q2 2024-$0.88-$1.55 -$0.67$4.91--2/14/2024Q1 2024-$1.00-$0.80+$0.20-$0.04--12/22/2023Q4 2023-$1.00-$1.00--$0.05-- Oncobiologics Earnings - Frequently Asked Questions When is Oncobiologics' earnings date? Oncobiologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 26th, 2025 based off last year's report dates. Learn more on OTLK's earnings history. Did Oncobiologics beat their earnings estimates last quarter? In the previous quarter, Oncobiologics (NASDAQ:OTLK) missed the analysts' consensus estimate of ($0.42) by $0.02 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. OTLK's actual earnings. How much profit does Oncobiologics generate each year? Oncobiologics (NASDAQ:OTLK) has a recorded net income of -$75.37 million. OTLK has generated -$0.57 earnings per share over the last four quarters. What is Oncobiologics' EPS forecast for next year? Oncobiologics' earnings are expected to grow from ($2.27) per share to ($0.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies FitLife Brands Earnings Journey Medical Earnings Scilex Earnings Forte Biosciences Earnings Milestone Pharmaceuticals Earnings Protalix BioTherapeutics Earnings Avalo Therapeutics Earnings Protara Therapeutics Earnings SELLAS Life Sciences Group Earnings BioHarvest Sciences Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:OTLK) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncobiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncobiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
